Dong Peng, MD
Pfizer Inc.
Pfizer China
Beijing
China
100010
Papers:
AN ECONOMIC MODEL TO COMPARE THE DIFFERENT EMPIRIC AND FIRST/SECOND LINE TREATMENT REGIMENS FOR SUSPECTED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NOSOCOMIAL PNEUMONIA IN CHINA